| # | Title | Journal | Year | Citations |
|---|
| 1 | Attitudes towards vaccines and intention to vaccinate against COVID-19: Implications for public health communications | Lancet Regional Health - Europe, The | 2021 | 670 |
| 2 | Post-COVID syndrome in non-hospitalised patients with COVID-19: a longitudinal prospective cohort study | Lancet Regional Health - Europe, The | 2021 | 452 |
| 3 | Dynamics of antibody response to BNT162b2 vaccine after six months: a longitudinal prospective study | Lancet Regional Health - Europe, The | 2021 | 446 |
| 4 | Humoral and cellular immunity to SARS-CoV-2 vaccination in renal transplant versus dialysis patients: A prospective, multicenter observational study using mRNA-1273 or BNT162b2 mRNA vaccine | Lancet Regional Health - Europe, The | 2021 | 231 |
| 5 | Long Covid in adults discharged from UK hospitals after Covid-19: A prospective, multicentre cohort study using the ISARIC WHO Clinical Characterisation Protocol | Lancet Regional Health - Europe, The | 2021 | 191 |
| 6 | Loneliness, worries, anxiety, and precautionary behaviours in response to the COVID-19 pandemic: A longitudinal analysis of 200,000 Western and Northern Europeans | Lancet Regional Health - Europe, The | 2021 | 180 |
| 7 | Household transmission of COVID-19 cases associated with SARS-CoV-2 delta variant (B.1.617.2): national case-control study | Lancet Regional Health - Europe, The | 2022 | 162 |
| 8 | Chronic diseases, health conditions and risk of COVID-19-related hospitalization and in-hospital mortality during the first wave of the epidemic in France: a cohort study of 66 million people | Lancet Regional Health - Europe, The | 2021 | 137 |
| 9 | Factors associated with deaths due to COVID-19 versus other causes: population-based cohort analysis of UK primary care data and linked national death registrations within the OpenSAFELY platform | Lancet Regional Health - Europe, The | 2021 | 121 |
| 10 | Ethnic differences in SARS-CoV-2 vaccine hesitancy in United Kingdom healthcare workers: Results from the UK-REACH prospective nationwide cohort study | Lancet Regional Health - Europe, The | 2021 | 116 |
| 11 | Effectiveness of heterologous ChAdOx1 nCoV-19 and mRNA prime-boost vaccination against symptomatic Covid-19 infection in Sweden: A nationwide cohort study | Lancet Regional Health - Europe, The | 2021 | 115 |
| 12 | Impact of SARS-CoV-2 Delta variant on incubation, transmission settings and vaccine effectiveness: Results from a nationwide case-control study in France | Lancet Regional Health - Europe, The | 2022 | 109 |
| 13 | Impact of the COVID-19 pandemic and associated non-pharmaceutical interventions on other notifiable infectious diseases in Germany: An analysis of national surveillance data during week 1–2016 – week 32–2020 | Lancet Regional Health - Europe, The | 2021 | 101 |
| 14 | Decreased infectivity following BNT162b2 vaccination: A prospective cohort study in Israel | Lancet Regional Health - Europe, The | 2021 | 101 |
| 15 | Mortality comparison between the first and second/third waves among 3,795 critical COVID-19 patients with pneumonia admitted to the ICU: A multicentre retrospective cohort study | Lancet Regional Health - Europe, The | 2021 | 99 |
| 16 | Trends in respiratory virus circulation following COVID-19-targeted nonpharmaceutical interventions in Germany, January - September 2020: Analysis of national surveillance data | Lancet Regional Health - Europe, The | 2021 | 95 |
| 17 | Prevalence of antibody positivity to SARS-CoV-2 following the first peak of infection in England: Serial cross-sectional studies of 365,000 adults | Lancet Regional Health - Europe, The | 2021 | 91 |
| 18 | Predictors of self-reported adherence to COVID-19 guidelines. A longitudinal observational study of 51,600 UK adults | Lancet Regional Health - Europe, The | 2021 | 90 |
| 19 | Emergence of the E484K mutation in SARS-COV-2-infected immunocompromised patients treated with bamlanivimab in Germany | Lancet Regional Health - Europe, The | 2021 | 83 |
| 20 | Lung cancer mortality reduction by LDCT screening: UKLS randomised trial results and international meta-analysis | Lancet Regional Health - Europe, The | 2021 | 82 |
| 21 | Adolescents’ symptoms of anxiety and depression before and during the Covid-19 outbreak – A prospective population-based study of teenagers in Norway | Lancet Regional Health - Europe, The | 2021 | 81 |
| 22 | Public health monitoring of cannabis use in Europe: prevalence of use, cannabis potency, and treatment rates | Lancet Regional Health - Europe, The | 2021 | 80 |
| 23 | Severe COVID-19 in people with type 1 and type 2 diabetes in Sweden: A nationwide retrospective cohort study | Lancet Regional Health - Europe, The | 2021 | 77 |
| 24 | Paediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 (PIMS-TS): Prospective, national surveillance, United Kingdom and Ireland, 2020 | Lancet Regional Health - Europe, The | 2021 | 73 |
| 25 | A look into the future of the COVID-19 pandemic in Europe: an expert consultation | Lancet Regional Health - Europe, The | 2021 | 72 |
| 26 | Prevalence, outcomes, and cost of chronic kidney disease in a contemporary population of 2·4 million patients from 11 countries: The CaReMe CKD study | Lancet Regional Health - Europe, The | 2022 | 72 |
| 27 | Prevalence of mental disorders, suicidal ideation and suicides in the general population before and during the COVID-19 pandemic in Norway: A population-based repeated cross-sectional analysis | Lancet Regional Health - Europe, The | 2021 | 70 |
| 28 | Impact of original, B.1.1.7, and B.1.351/P.1 SARS-CoV-2 lineages on vaccine effectiveness of two doses of COVID-19 mRNA vaccines: Results from a nationwide case-control study in France | Lancet Regional Health - Europe, The | 2021 | 70 |
| 29 | Predictors of uncertainty and unwillingness to receive the COVID-19 booster vaccine: An observational study of 22,139 fully vaccinated adults in the UK | Lancet Regional Health - Europe, The | 2022 | 70 |
| 30 | The burden of mental disorders, substance use disorders and self-harm among young people in Europe, 1990–2019: Findings from the Global Burden of Disease Study 2019 | Lancet Regional Health - Europe, The | 2022 | 70 |
| 31 | SARS-CoV-2 transmission risk from asymptomatic carriers: Results from a mass screening programme in Luxembourg | Lancet Regional Health - Europe, The | 2021 | 68 |
| 32 | Risk assessment and seroprevalence of SARS-CoV-2 infection in healthcare workers of COVID-19 and non-COVID-19 hospitals in Southern Switzerland | Lancet Regional Health - Europe, The | 2021 | 66 |
| 33 | Climate change and infectious disease in Europe: Impact, projection and adaptation | Lancet Regional Health - Europe, The | 2021 | 64 |
| 34 | Tinnitus prevalence in Europe: a multi-country cross-sectional population study | Lancet Regional Health - Europe, The | 2022 | 63 |
| 35 | The dawn of digital public health in Europe: Implications for public health policy and practice | Lancet Regional Health - Europe, The | 2022 | 61 |
| 36 | A cross-sectional and prospective cohort study of the role of schools in the SARS-CoV-2 second wave in Italy | Lancet Regional Health - Europe, The | 2021 | 59 |
| 37 | Exposures associated with SARS-CoV-2 infection in France: A nationwide online case-control study | Lancet Regional Health - Europe, The | 2021 | 57 |
| 38 | Evaluating social and spatial inequalities of large scale rapid lateral flow SARS-CoV-2 antigen testing in COVID-19 management: An observational study of Liverpool, UK (November 2020 to January 2021) | Lancet Regional Health - Europe, The | 2021 | 56 |
| 39 | Monitoring SARS-CoV-2 variants alterations in Nice neighborhoods by wastewater nanopore sequencing | Lancet Regional Health - Europe, The | 2021 | 56 |
| 40 | Severity of Omicron (B.1.1.529) and Delta (B.1.617.2) SARS-CoV-2 infection among hospitalised adults: a prospective cohort study in Bristol, United Kingdom | Lancet Regional Health - Europe, The | 2023 | 55 |
| 41 | The role of organizational characteristics on the outcome of COVID-19 patients admitted to the ICU in Belgium | Lancet Regional Health - Europe, The | 2021 | 53 |
| 42 | Repeated centralized multidisciplinary team assessment of resectability, clinical behavior, and outcomes in 1086 Finnish metastatic colorectal cancer patients (RAXO): A nationwide prospective intervention study | Lancet Regional Health - Europe, The | 2021 | 50 |
| 43 | Trends and the course of liver cirrhosis and its complications in Germany: Nationwide population-based study (2005 to 2018) | Lancet Regional Health - Europe, The | 2022 | 50 |
| 44 | An open, non-randomised, phase 1/2 trial on the safety, tolerability, and immunogenicity of single-dose vaccine “Sputnik Light” for prevention of coronavirus infection in healthy adults | Lancet Regional Health - Europe, The | 2021 | 50 |
| 45 | Influence of socioeconomic deprivation on interventions and outcomes for patients admitted with COVID-19 to critical care units in Scotland: A national cohort study | Lancet Regional Health - Europe, The | 2021 | 49 |
| 46 | A nationwide analysis of population group differences in the COVID-19 epidemic in Israel, February 2020–February 2021 | Lancet Regional Health - Europe, The | 2021 | 49 |
| 47 | Suicide in England in the COVID-19 pandemic: Early observational data from real time surveillance | Lancet Regional Health - Europe, The | 2021 | 48 |
| 48 | Long COVID risk - a signal to address sex hormones and women's health | Lancet Regional Health - Europe, The | 2021 | 48 |
| 49 | Long-term real-world effectiveness of allergy immunotherapy in patients with allergic rhinitis and asthma: Results from the REACT study, a retrospective cohort study. | Lancet Regional Health - Europe, The | 2022 | 48 |
| 50 | Risk and severity of SARS-CoV-2 reinfections during 2020–2022 in Vojvodina, Serbia: A population-level observational study | Lancet Regional Health - Europe, The | 2022 | 47 |
